VTR:NYE-Ventas Inc. (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 43.63

Change

+1.28 (+3.02)%

Market Cap

USD 21.02B

Volume

2.67M

Analyst Target

USD 38.42
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ventas Inc is a real estate investment trust. The Company has diversified portfolio of seniors housing and healthcare properties located throughout the United States, Canada and the United Kingdom.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

USD 55.76B
DOC Healthpeak Properties Inc

N/A

USD 12.76B
OHI Omega Healthcare Investors Inc

N/A

USD 7.67B
HR Healthcare Realty Trust Incorp..

N/A

USD 5.39B
CTRE CareTrust REIT Inc.

N/A

USD 3.28B
NHI National Health Investors Inc

N/A

USD 2.54B
MPW Medical Properties Trust Inc

N/A

USD 2.43B
AHR American Healthcare REIT Inc

N/A

USD 1.65B
LTC LTC Properties Inc

N/A

USD 1.38B
CHCT Community Healthcare Trust Inc

N/A

USD 0.71B

ETFs Containing VTR

BYRE Principal Exchange-Traded.. 7.56 % 0.00 %

N/A

USD 8.60M
WTRE WisdomTree New Economy Re.. 5.37 % 0.00 %

N/A

USD 0.02B
JPRE JPMorgan Realty Income ET.. 5.13 % 0.00 %

N/A

USD 0.31B
WNER:LSE WisdomTree New Economy Re.. 5.05 % 0.00 %

N/A

USD 2.48M
WTNR:LSE WisdomTree New Economy Re.. 5.05 % 0.00 %

N/A

USD 2.48M
WNEW:LSE WisdomTree New Economy Re.. 5.05 % 0.00 %

N/A

USD 0.82M
WTRE:LSE WisdomTree New Economy Re.. 5.05 % 0.00 %

N/A

USD 1.65M
WTRE:XETRA WisdomTree New Economy Re.. 5.00 % 0.00 %

N/A

USD 2.55M
WTER:XETRA WisdomTree New Economy Re.. 5.00 % 0.00 %

N/A

USD 2.33M
CSYZ:F Credit Suisse Index Fund .. 4.23 % 0.00 %

N/A

USD 0.22B
GREIT:SW Credit Suisse Index Fund .. 4.23 % 0.00 %

N/A

USD 0.22B
RENT:AU 2.03 % 0.00 %

N/A

N/A
DRW 0.00 % 0.58 %

N/A

N/A
EWRE 0.00 % 0.40 %

N/A

N/A
REZ iShares Residential and M.. 0.00 % 0.48 %

N/A

USD 0.62B
OLD 0.00 % 0.50 %

N/A

N/A
WREI 0.00 % 0.32 %

N/A

N/A
CGRE:CA CI Global REIT Private Po.. 0.00 % 0.00 %

N/A

CAD 0.10B
CSYZ:XETRA Credit Suisse Index Fund .. 0.00 % 0.00 %

N/A

USD 0.22B
BLLD J.P. Morgan Exchange-Trad.. 0.00 % 0.00 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.46% 31% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.46% 31% F 8% B-
Trailing 12 Months  
Capital Gain -0.80% 50% F 27% F
Dividend Return 4.09% 20% F 59% D-
Total Return 3.30% 44% F 28% F
Trailing 5 Years  
Capital Gain -31.63% 33% F 17% F
Dividend Return 15.55% 8% B- 60% D-
Total Return -16.08% 33% F 17% F
Average Annual (5 Year Horizon)  
Capital Gain -2.24% 77% C+ 31% F
Dividend Return 1.69% 69% C- 37% F
Total Return 3.93% 15% F 72% C
Risk Return Profile  
Volatility (Standard Deviation) 35.18% 8% B- 30% F
Risk Adjusted Return 4.80% 69% C- 32% F
Market Capitalization 21.02B 94% A 89% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 36.00 7% 0%
Price/Book Ratio 1.88 50% 44%
Price / Cash Flow Ratio 14.97 24% 24%
Price/Free Cash Flow Ratio 15.93 31% 22%
Management Effectiveness  
Return on Equity -0.30% 35% 28%
Return on Invested Capital 2.94% 47% 35%
Return on Assets 1.65% 29% 40%
Debt to Equity Ratio 142.04% 12% 22%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.